Pickthorn Sean, Terpstra Erin, Conde Tania Padilla, Kolba Joe, Ali Mir
University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Internal Medicine Residency Program, University of Iowa Health Care, Iowa City, Iowa.
S D Med. 2019 Sep;72(9):414-417.
Use of procedural sedation to promote anxiolysis, analgesia, and amnesia enhances both pediatric patient experience and procedural outcomes. Sanford Children's outpatient sedation clinic currently uses oral midazolam for minimal sedation.
A research survey was designed to evaluate parent/guardian satisfaction with midazolam for pediatric sedation in simple outpatient procedures including, bot linum toxin injections, voiding cystourethrogram (VCUG), and intravenous line placement. Parents'/ guardians' understanding of the sedation and procedural logistics were surveyed and their satisfaction with the child's comfort, recovery time, and overall satisfaction were assessed. Each component was rated on a scale of 1-10, 1 being not satisfied and 10 as extremely satisfied.
The study was conducted at a single pediatric outpatient center. Forty-one parents/guardians of patients aged 22 months-17 years were recruited; of these, 41 consented and enrolled in the study. Average age was 6.1 years with 22 females and 19 males. Of the surveys collected, 30 were botulinum toxin injections, eight VCUG, one contrast enema, and two were not recorded. Mean survey results were 8.7 (95 percent CI, 8.2-9.2) for satisfaction of recovery time, 8.0 (95 percent CI, 7.4-8.6) for control of discomfort and 8.4 (95 percent CI, 7.9-8.9) for overall satisfaction.
When evaluating midazolam as a sedation agent in pediatric procedures, parents/guardians were most satisfied with the duration of recovery and had the lowest satisfaction on control of the patient's discomfort. Overall, it can be concluded that midazolam is a moderately good agent for pediatric patients receiving minimal sedation, with the greatest satisfaction in the duration of recovery.
使用程序性镇静来促进抗焦虑、镇痛和失忆，可提升儿科患者的体验及诊疗效果。桑福德儿童门诊镇静诊所目前使用口服咪达唑仑进行浅镇静。
设计了一项研究调查，以评估家长/监护人对咪达唑仑用于儿科简单门诊手术镇静的满意度，这些手术包括肉毒杆菌毒素注射、排尿性膀胱尿道造影（VCUG）和静脉置管。调查了家长/监护人对镇静及诊疗流程的理解，并评估了他们对孩子舒适度、恢复时间和总体满意度。每个项目的评分范围为1至10分，1分为不满意，10分为极其满意。
该研究在一家儿科门诊中心进行。招募了41名年龄在22个月至17岁患者的家长/监护人；其中，41人同意并参与了研究。平均年龄为6.1岁，女性22人，男性19人。收集的调查中，30例为肉毒杆菌毒素注射，8例为VCUG，1例为对比灌肠，2例未记录。恢复时间满意度的平均调查结果为8.7（95%置信区间，8.2 - 9.2），不适控制方面为8.0（95%置信区间，7.4 - 8.6），总体满意度为8.4（95%置信区间，7.9 - 8.9）。
在评估咪达唑仑作为儿科手术镇静剂时，家长/监护人对恢复时间最满意，对患者不适控制的满意度最低。总体而言，可以得出结论，咪达唑仑对于接受浅镇静的儿科患者是一种中等良好的药物，在恢复时间方面满意度最高。
